Literature DB >> 22017431

Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Joanne M Hildebrand1, Zuoan Yi, Claire M Buchta, Jayakumar Poovassery, Laura L Stunz, Gail A Bishop.   

Abstract

A large and diverse group of receptors utilizes the family of cytoplasmic signaling proteins known as tumor necrosis factor receptor (TNFR)-associated factors (TRAFs). In recent years, there has been a resurgence of interest and exploration of the roles played by TRAF3 and TRAF5 in cellular regulation, particularly in cells of the immune system, the cell types of focus in this review. This work has revealed that TRAF3 and TRAF5 can play diverse roles for different receptors even in the same cell type, as well as distinct roles in different cell types. Evidence indicates that TRAF3 and TRAF5 play important roles beyond the TNFR-superfamily (SF) and viral mimics of its members, mediating certain innate immune receptor and cytokine receptor signals, and most recently, signals delivered by the T-cell receptor (TCR) signaling complex. Additionally, much research has demonstrated the importance of TRAF3-mediated cellular regulation via its cytoplasmic interactions with additional signaling proteins. In particular, we discuss below evidence for the participation by TRAF3 in a number of the regulatory post-translational modifications involving ubiquitin that are important in various signaling pathways.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017431      PMCID: PMC3202299          DOI: 10.1111/j.1600-065X.2011.01055.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  184 in total

1.  Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes.

Authors:  Tony J Vanden Bush; Claire M Buchta; Jennifer Claudio; Gail A Bishop
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

2.  Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6.

Authors:  Shu Li; Hao Zheng; Ai-Ping Mao; Bo Zhong; Ying Li; Yu Liu; Yan Gao; Yong Ran; Po Tien; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

3.  The contribution of direct TLR signaling to T cell responses.

Authors:  Adeeb H Rahman; Devon K Taylor; Laurence A Turka
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

5.  TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.

Authors:  Eric D Tang; Cun-Yu Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 6.  Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis.

Authors:  Melissa E Munroe
Journal:  Semin Immunol       Date:  2009-06-17       Impact factor: 11.130

7.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.

Authors:  Ping-Hui Tseng; Atsushi Matsuzawa; Weizhou Zhang; Takashi Mino; Dario A A Vignali; Michael Karin
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

8.  TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.

Authors:  Zachary J Kraus; Hiroyasu Nakano; Gail A Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

9.  The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.

Authors:  Peyman Nakhaei; Thibault Mesplede; Mayra Solis; Qiang Sun; Tiejun Zhao; Long Yang; Tsung-Hsien Chuang; Carl F Ware; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

10.  Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.

Authors:  Michael W Tusche; Lesley A Ward; Frances Vu; Doug McCarthy; Miguel Quintela-Fandino; Jurgen Ruland; Jennifer L Gommerman; Tak W Mak
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

View more
  49 in total

1.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

2.  Microarray expression profile of circular RNAs and mRNAs in children with systemic lupus erythematosus.

Authors:  Shipeng Li; Junmei Zhang; Xiaohua Tan; Jianghong Deng; Yan Li; Yurong Piao; Chao Li; Wenxu Yang; Wenxiu Mo; Jiapeng Sun; Fei Sun; Tongxin Han; Jiang Wang; Weiying Kuang; Caifeng Li
Journal:  Clin Rheumatol       Date:  2019-01-09       Impact factor: 2.980

Review 3.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Nuclear TRAF3 is a negative regulator of CREB in B cells.

Authors:  Nurbek Mambetsariev; Wai W Lin; Laura L Stunz; Brett M Hanson; Joanne M Hildebrand; Gail A Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

5.  The kinase CK1ɛ controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3.

Authors:  Yilong Zhou; Chenxi He; Dapeng Yan; Feng Liu; Haipeng Liu; Jianxia Chen; Ting Cao; Mianyong Zuo; Peng Wang; Yan Ge; Haojie Lu; Qinghe Tong; Chengfeng Qin; Yongqiang Deng; Baoxue Ge
Journal:  Nat Immunol       Date:  2016-02-29       Impact factor: 25.606

6.  Intracellular Signaling Pathways in Rheumatoid Arthritis.

Authors:  Charles J Malemud
Journal:  J Clin Cell Immunol       Date:  2013-08-19

7.  The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.

Authors:  Pradeep Bangalore-Prakash; Laura L Stunz; Nurbek Mambetsariev; Amy L Whillock; Bruce S Hostager; Gail A Bishop
Journal:  Blood Adv       Date:  2017-12-18

Review 8.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

Review 9.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

10.  TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.

Authors:  Jianbin Yang; Dongyi Wei; Weixin Wang; Baohong Shen; Suling Xu; Yuan Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.